The American Heart Association has announced a Data Grant focused on cardiovascular, kidney, and metabolic (CKM) disease in people with current or prior cancer. The initiative funds analyses of real‑world data to quantify and address CKM prevalence, treatment patterns, shared risk factors and outcomes in cancer patients and survivors, and prioritizes use of large datasets such as electronic health records, registries, or claims databases.
Eligible applicants are independent investigators at academic, clinical, or public‑health institutions worldwide. Proposals must center on cancer patients or survivors and CKM disease; multidisciplinary teams that include oncology, cardiology, nephrology, epidemiology and data science expertise are encouraged. Applicants must have the ability to access and securely analyze appropriate real‑world datasets.
The grant is a targeted AHA research award designed for projects that leverage large real‑world datasets. Budgets and project durations must conform to AHA policies for this request for proposals, with applicants submitting justified budgets within program limits. Indirect costs are capped according to current AHA rules.
Key deadlines are a Letter of Intent due January 19, 2026, and, by invitation, a full application due March 23, 2026. The earliest possible project start date is August 1, 2026.
Program details and application instructions are available on the American Heart Association website.
Leave a Reply